How has Ashland's life sciences — research and development expense changed year-over-year?

Ashland's life sciences — research and development expense decreased by 25.0% year-over-year, from $4M to $3M.

What does life sciences — research and development expense mean?

This represents the investment made by the segment in discovering, developing, and improving products, technologies, or processes. It is a leading indicator of the segment's commitment to innovation and long-term competitive advantage. Sustained investment here is typically necessary to maintain market position and drive future revenue growth.

Ashland ASH Life Sciences — Research And Development Expense

Other segment segments

Personal Care And Household

$6M-14.3%

Specialty Additives

$4M+33.3%

Unallocated And Other

$1M—

Intermediates And Solvents

$0—

Similar metrics at other companies

TMOLife Sciences Solutions — Research and development expenses

$131M-5.8%

RVTYLife Sciences — Segment research and development expenses

$31.62M+11.9%

STELife Sciences: — R&D

$2.8M+16.7%

GLW

GLWLife Sciences and Emerging Growth Businesses — Research, development and engineering expenses

$28M-6.7%

ALife Sciences and Diagnostics Markets — Research and Development Expense

$64M+8.5%

BCCorporate Segment — Research and Development Expense

$1.1M+10.0%

Other financials

Income statement

See full

Revenue$482.0M+0.6%

Gross profit$147.0M0.0%

Operating income$39.0M-23.5%

Net income$16.0M-48.4%

EPS (diluted)$0.34-47.7%

Balance sheet

See full

Cash & equivalents$343.0M+104%

Total debt$1.5B-0.6%

Total equity$1.9B-27.1%

Total assets$4.5B-14.0%

Cash flow

See full

Operating cash flow$50.0M+456%

CapEx$17.0M-19.0%

Free cash flow$33.0M+375%

Valuation

See full

Market cap$2.93B-9.0%

Enterprise value$4.06B-10.6%

P/S1.6×0.0×

Profitability

See full

Gross margin30%-1.7pp

Operating margin-37.3%—

Net margin-40.8%-48.8pp

FCF margin13.6%+9.7pp

Returns & leverage

See full

Return on equity-33.4%-38.5pp

Debt / equity0.8×+0.2×

Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ashland's life sciences — research and development expense?: Ashland (ASH) reported life sciences — research and development expense of $3M in Q1 2026.
How has Ashland's life sciences — research and development expense changed year-over-year?: Ashland's life sciences — research and development expense decreased by 25.0% year-over-year, from $4M to $3M.
What does life sciences — research and development expense mean?: This represents the investment made by the segment in discovering, developing, and improving products, technologies, or processes. It is a leading indicator of the segment's commitment to innovation and long-term competitive advantage. Sustained investment here is typically necessary to maintain market position and drive future revenue growth.